This site is intended for Healthcare professionals only.

Pancreatitis reduced by nearly 50 percenct after gene therapy to treat lipoprotein lipase deficiency


Pancreatitis reduced by nearly 50 percenct after gene therapy to treat lipoprotein lipase deficiency

Over a 6-year period, patients with the genetic disease lipoprotein lipase deficiency (LPLD) who received a single gene therapy treatment of alipogene tiparvovec had a marked reduction in the severity and frequency of pancreatitis. No cases of severe pancreatitis and only one admission to the intensive care unit for an LPLD-related abdominal event were reported in the study published in Human Gene Therapy.

Daniel Gaudet and coauthors from Université de Montréal, Canada, Academic Medical Center and uniQure BV (Amsterdam, the Netherlands), Chiesi Farmaceutici (Parma, Italy), Beaujon Hospital, Denis Diderot University (Paris, France), University Hospital of North Midlands (U.K.), and Erasmus Medical Centre (Rotterdam, the Netherlands) present their findings in the article entitled “Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.”

The researchers assessed LPLD-related acute abdominal events that required hospital care in a small group of patients treated with a single dose of the gene therapy product Glybera®. The results support an association between gene therapy for this rare genetic disease and overall reductions in healthcare costs and resource utilization.

“As gene therapy moves forward into the mainstream of medicine, it will be critical to define the evidence of its benefit to patients with specific diseases,” says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA. “This work with alipogene tiparvovec provides an evidence-based guideline for its use in patients with LPLD going forward.”

You can read the full Article by clicking on the link :

Daniel Gaudet, Erik S. Stroes, Julie Méthot, Diane Brisson, Karine Tremblay, Sophie J. Bernelot Moens, Giorgio Iotti, Irene Rastelletti, Diego Ardigo, Deyanira Corzo, Christian Meyer, Marc Andersen, Philippe Ruszniewski, Mark Deakin, Marco J. Bruno. Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis. Human Gene Therapy, 2016; DOI: 10.1089/hum.2015.158

The following two tabs change content below.
supriya kashyap

supriya kashyap

Supriya Kashyap Joined Medical Dialogue as Reporter in 2015 . she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Delhi University. She can be contacted at supriya.kashyap@medicaldialogues.in Contact no. 011-43720751
Source: self

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted